Junichiro Watanabe

6.0k citations
127 papers · 1.6k · h-index 22

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
  • Radiology, Nuclear Medicine and Imaging top 5%
    • MRI in cancer diagnosis
    • Radiomics and Machine Learning in Medical Imaging
    • Medical Imaging Techniques and Applications

Papers in

Co-authors
Takayoshi Uematsu (15 shared papers)Masako Kasami (8 shared papers)Kaoru Takahashi (11 shared papers)Yukiko Tadokoro (10 shared papers)Hiroji Iwata (9 shared papers)Haruki Kondo (6 shared papers)Toshiaki Saeki (5 shared papers)Takashi Sugino (7 shared papers)
Journals
Annals of Oncology (14 papers)Breast Cancer Research and Treatment (9 papers)Breast Cancer (9 papers)Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)
Partner nations
JapanUnited StatesSouth Korea

In The Last Decade

Junichiro Watanabe

115 papers receiving 1.5k citations

Peers

Junichiro Watanabe
Comparison fields: 5 of 97
  • Oncology 508
  • Radiology, Nuclear Medicine and Imaging 351
  • Cancer Research 180
  • Pulmonary and Respiratory Medicine 267
  • Biomaterials 108
Replace Allyson J. Ocean with:
Allyson J. Ocean United States
Hani M. Babiker United States
Hong Ge China
Peter Ang Singapore
Akihiko Osaki Japan
Michael J. Guarino United States
Hubing Wu China
Vijayakrishna K. Gadi United States
Keigo Yorozu United States
Johanna W. Wilmink Netherlands
Junichiro Watanabe relative to Allyson J. Ocean United States Allyson J. Ocean's profile →
Citations per field
00.5×2×3×3.6×
Allyson J. Ocean · 1×
Citations per year

Countries citing papers authored by Junichiro Watanabe

Since Specialization
Citations

This map shows the geographic impact of Junichiro Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichiro Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichiro Watanabe more than expected).

Fields of papers citing papers by Junichiro Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichiro Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichiro Watanabe. The network helps show where Junichiro Watanabe may publish in the future.

Co-authors

The 25 scholars most cited alongside Junichiro Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junichiro Watanabe Line = papers co-authored together Junichiro Watanabe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparison of FDG PET and SPECT for Detection of Bone Metastases in Breast Cancer
American Journal of Roentgenology ·Takayoshi Uematsu, Sachiko Yuen, Seigo Yukisawa, Takeshi Aramaki, Naoki Morimoto, Masahiro Endo, Hiroyoshi Furukawa, Yoshihiro Uchida, Junichiro Watanabe
2005111
2
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
British Journal of Cancer ·Yasuhiro Fujiwara, Hirofumi Mukai, Toshiaki Saeki, Jungsil Ro, Yung‐Chang Lin, Shigenori E. Nagai, Keun Seok Lee, Junichiro Watanabe, Shoichiro Ohtani, Sung Bae Kim, Katsumasa Kuroi, Koichiro Tsugawa, Yutaka Tokuda, Hiroji Iwata, (unknown), Youngsen Yang, Yoshihiro Nambu
2019110
3
Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?
European Radiology ·Takayoshi Uematsu, Masako Kasami, Junichiro Watanabe
201185
4
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
British Journal of Cancer ·Masakazu Toi, Hiroji Iwata, Yasuhiro Fujiwara, Yoshiaki Ito, Shôji Nakamura, Yutaka Tokuda, Tetsuya Taguchi, Yoshiaki Rai, K. Aogi, T Arai, Junichiro Watanabe, T. Wakamatsu, Koichi Katsura, Catherine Ellis, Robert Gagnon, Kathleen Allen, Yosuke Sasaki, Shigemitsu Takashima
200970
5
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors
Investigational New Drugs ·Toshiaki Takahashi, Narikazu Boku, Haruyasu Murakami, Tateaki Naito, Asuka Tsuya, Yukiko Nakamura, Akira Ono, Nozomu Machida, Kentaro Yamazaki, Junichiro Watanabe, Ana Ruiz-Garcı́a, Keiji Imai, Emiko Ohki, Nobuyuki Yamamoto
201256
6
Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer?
Breast Cancer ·Takayoshi Uematsu, Masako Kasami, Junichiro Watanabe
201355
7
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study
Breast Cancer ·Yasuo Miyoshi, Yuta Yoshimura, Kenichi Saito, Kenzo Muramoto, Michiko SUGAWARA, Karenza Alexis, K. Nomoto, Seigo Nakamura, Toshiaki Saeki, Junichiro Watanabe, José Manuel Pérez-García, Javier Cortés
202046
8
Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy
Radiology ·Taiyo L. Harada, Takayoshi Uematsu, Kazuaki Nakashima, Takanori Kawabata, Seiichirou Nishimura, Kaoru Takahashi, Yukiko Tadokoro, Tomomi Hayashi, Kazuyo Tsuchiya, Junichiro Watanabe, Takashi Sugino
202141
9
Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan
Clinical Pharmacology & Therapeutics ·Ophelia Yin, Hiroji Iwata, Chia‐Chi Lin, Kenji Tamura, Junichiro Watanabe, Russ Wada, Helen Kastrissios, Malaz Abutarif, Τushar Garimella, Caleb Lee, Lin Zhang, Javad Shahidi, Frank LaCreta
202138
10
Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?
Breast Cancer ·Takayoshi Uematsu, Masako Kasami, Junichiro Watanabe, Kaoru Takahashi, Seiji Yamasaki, Kumiko Tanaka, Yukiko Tadokoro, Akiko Ogiya
201035
11
Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. The Gastrointestinal Physiology Working Group of the Cayetano Heredia and the Johns Hopkins University.
Gut ·Cayetano Heredia, Robert H. Gilman, Alberto Ramírez‐Ramos, William M. Spira, Sixto Recavarren, Junichiro Watanabe, Raul León‐Barúa, C Rodríguez, C. Ladrón de Guevara, Guadalupe Fernández Gago, J Bonilla, Jaime Cok, Huidobro Ruiz, Eleanor Gomez, Enrique G. Olivares, Garrido Klinge, German Vargas G., Magdalena Astete, Meica Valdivia, R. Berendson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)
199229
12
Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up
Breast Cancer Research and Treatment ·Satomi Matsuo, Junichiro Watanabe, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Mitsuhiro Hayashi
201728
13
Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?
European Radiology ·Taiyo L. Harada, Takayoshi Uematsu, Kazuaki Nakashima, Takashi Sugino, Seiichirou Nishimura, Kaoru Takahashi, Tomomi Hayashi, Yukiko Tadokoro, Junichiro Watanabe, Shogo Nakamoto, Takahiro Ito
202028
14
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology ·Toshihiko Doi, Yusuke Onozawa, Nozomu Fuse, Takayuki Yoshino, Kentaro Yamazaki, Junichiro Watanabe, Mikhail Akimov, Matthew Robson, Narikazu Boku, Atsushi Ohtsu
201427
15
Real-time virtual sonography examination and biopsy for suspicious breast lesions identified on MRI alone
European Radiology ·Takayoshi Uematsu, Kaoru Takahashi, Seiichiro Nishimura, Junichiro Watanabe, Seiji Yamasaki, Takashi Sugino, Takuma Oishi, Yuko Kakuda, Mutsu Sato, Tomomi Hayashi
201527
16
High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
Breast Cancer Research ·Hiroko Onagi, Yoshiya Horimoto, Asumi Sakaguchi, Daiki Ikarashi, Naotake Yanagisawa, Takayuki Nakayama, Tetsuya Nakatsura, Yumiko Ishizuka, Ritsuko Sasaki, Junichiro Watanabe, Mitsue Saito, Harumi Saeki, Takuo Hayashi, Atsushi Arakawa, Takashi Yao, Shigehisa Kitano
202226
17
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours
Investigational New Drugs ·Yasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, Hirofumi Yasui, Isao Goto, Kentaro Yamazaki, Nozomu Machida, Junichiro Watanabe, Hitoshi Shimada, Xiaojin Shi, Narikazu Boku
201225
18
Should breast MRI be performed with adjustment for the phase in patients’ menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients’ menstrual cycle
European Journal of Radiology ·Takayoshi Uematsu, Masako Kasami, Junichiro Watanabe
201124
19
Eribulin monotherapy improved survivals in patients with ER-positive HER2-negative metastatic breast cancer in the real world: a single institutional review
SpringerPlus ·Junichiro Watanabe
201524
20
Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology ·Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto, Junichiro Watanabe, Narikazu Boku, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Satoru Otani, Kazuhiro Shibayama, Takatoshi Takubo, Elwyn Loh
201223

About Junichiro Watanabe

Junichiro Watanabe is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 127 papers that have together received 1.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (22 papers), Cancer Treatment and Pharmacology (20 papers), Breast Cancer Treatment Studies (11 papers), Advanced Breast Cancer Therapies (11 papers), Lung Cancer Treatments and Mutations (9 papers), MRI in cancer diagnosis (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Oncology (508 citations), Radiology, Nuclear Medicine and Imaging (351 citations), Cancer Research (180 citations), Pulmonary and Respiratory Medicine (267 citations) and Biomaterials (108 citations). Junichiro Watanabe has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Takayoshi Uematsu, Masako Kasami, Kaoru Takahashi, Yukiko Tadokoro, Hiroji Iwata, Haruki Kondo, Toshiaki Saeki, Takashi Sugino, Takeshi Aramaki and Yutaka Tokuda. Their work appears in journals such as Annals of Oncology, Breast Cancer Research and Treatment, Breast Cancer, Cancer Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allyson J. OceanBreakdown of academic impact, for papers by Hani M. BabikerBreakdown of academic impact, for papers by Hong GeBreakdown of academic impact, for papers by Peter AngBreakdown of academic impact, for papers by Akihiko OsakiBreakdown of academic impact, for papers by Michael J. GuarinoBreakdown of academic impact, for papers by Hubing WuBreakdown of academic impact, for papers by Vijayakrishna K. GadiBreakdown of academic impact, for papers by Keigo YorozuBreakdown of academic impact, for papers by Johanna W. Wilmink